J02AA01 - Amphotericin B |
Probably not porphyrinogenic |
PNP |
Mono.Rationale
Probably not significantly metabolised. Three references state non-porphyrinogenicity.
Mono.ChemicalDescription
Antimycotic substance for systemic use in candidemia and other severe generalized fungal infections. Obtained from from Streptomyces nodosus. Stored in the body for long periods, being slowly excreted in unchanged form in urine. Amphotericin B has been shown to decrease hepatic CYP content and function in rat studies. In contrast liposomal preparations of the substance do not give rise to this effect.
Mono.IpnetDrugReports
Uneventful use reported in 1 patient with acute porphyria.
Mono.SimilarDrugs
Mono.References
| # | Citation details | PubMed ID |
|---|---|---|
| Porphyria Drug Lists | ||
| 1. | French List
Centre Français des Porphyries
|
|
| 2. | EPI List
European Porphyria Initiative No longer maintained
|
|
| 3. | South African List
Porphyria South Africa No longer maintained
|
|
Mono.Tradenames